Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.25 GBX | -0.57% | -4.95% | -62.88% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 01 | Avacta picks Christina Coughlin to replace long-serving CEO | AN |
Sales 2023 | 23.25M 29.41M | Sales 2024 * | 24.5M 31M | Capitalization | 155M 196M |
---|---|---|---|---|---|
Net income 2023 | -24M -30.37M | Net income 2024 * | -27M -34.16M | EV / Sales 2023 | 14 x |
Net cash position 2023 * | 16.2M 20.5M | Net cash position 2024 * | 3.01M 3.81M | EV / Sales 2024 * | 6.18 x |
P/E ratio 2023 |
-12.7
x | P/E ratio 2024 * |
-5.62
x | Employees | 120 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 70.66% |
Latest transcript on Avacta Group Plc
1 day | -2.28% | ||
1 week | -6.57% | ||
Current month | -7.08% | ||
1 month | -14.55% | ||
3 months | -54.53% | ||
6 months | -68.65% | ||
Current year | -63.51% |
Managers | Title | Age | Since |
---|---|---|---|
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 16-01-03 |
Matt Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 13-09-15 |
Michael Vinegrad
IRO | Public Communications Contact | - | 14-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Nicholls
BRD | Director/Board Member | 67 | 13-08-01 |
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 16-01-03 |
Paul Fry
BRD | Director/Board Member | 58 | 20-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 43.25 | -0.57% | 1 341 586 |
24-05-16 | 43.5 | -1.69% | 1,361,347 |
24-05-15 | 44.25 | -1.12% | 1,450,867 |
24-05-14 | 44.75 | +1.02% | 1,115,547 |
24-05-13 | 44.3 | -2.64% | 1,075,841 |
Delayed Quote London S.E., May 17, 2024 at 07:44 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-63.51% | 196M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.12% | 22.28B | |
-11.90% | 22.41B | |
-5.52% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- AVCT Stock